BR9809778A - Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico. - Google Patents

Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.

Info

Publication number
BR9809778A
BR9809778A BR9809778-4A BR9809778A BR9809778A BR 9809778 A BR9809778 A BR 9809778A BR 9809778 A BR9809778 A BR 9809778A BR 9809778 A BR9809778 A BR 9809778A
Authority
BR
Brazil
Prior art keywords
antibody
polypeptide
producing
expression vector
single chain
Prior art date
Application number
BR9809778-4A
Other languages
English (en)
Inventor
Scott R Presnell
Teresa Gilbert
Theodore E Whitmore
Donald C Foster
Charles E Hart
Joyce M Lehner
Theresa Martinez
Ross C Hoffmann
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of BR9809778A publication Critical patent/BR9809778A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

"POLINUCLEOTìDEO ISOLADO, VETOR DE EXPRESSãO, PEPTìDEO OU POLIPEPTìDEO ISOLADO, ANTICORPO, PROCESSO PARA PRODUZIR O MESMO, FRAGMENTOS DE ANTICORPOS, ANTICORPOS DE CADEIA úNICA OU ANTICORPOS HUMANIZADOS, E, ANTICORPO ANTI-IDIOTìPICO". Novos polipeptídeos zcyto7 de mamíferos, polinucleotídeos codificando os polipeptídeos e composições relacionadas e processos incluindo os anticorpos e anticorpos anti-idiotípicos.
BR9809778-4A 1997-04-25 1998-04-23 Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico. BR9809778A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4488697P 1997-04-25 1997-04-25
US84575397A 1997-04-25 1997-04-25
US854398A 1998-01-16 1998-01-16
US7167698P 1998-01-16 1998-01-16
PCT/US1998/008212 WO1998049310A1 (en) 1997-04-25 1998-04-23 Mammalian cytokine-like factor 7

Publications (1)

Publication Number Publication Date
BR9809778A true BR9809778A (pt) 2000-06-20

Family

ID=27485789

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809778-4A BR9809778A (pt) 1997-04-25 1998-04-23 Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.

Country Status (16)

Country Link
EP (1) EP0977861B1 (pt)
JP (1) JP4216343B2 (pt)
KR (1) KR20010012111A (pt)
CN (1) CN1258315A (pt)
AT (1) ATE269901T1 (pt)
AU (1) AU736362B2 (pt)
BR (1) BR9809778A (pt)
CA (1) CA2288360A1 (pt)
DE (1) DE69824719T2 (pt)
EA (1) EA199900869A1 (pt)
ES (1) ES2223127T3 (pt)
IL (1) IL132496A0 (pt)
NO (1) NO995182L (pt)
NZ (1) NZ500885A (pt)
PL (1) PL336470A1 (pt)
WO (1) WO1998049310A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
WO1999060127A2 (en) 1998-05-15 1999-11-25 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6486301B1 (en) * 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
JP2001510035A (ja) * 1997-07-16 2001-07-31 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド インターロイキン−２０
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
AU2031399A (en) * 1998-01-09 1999-07-26 Immunex Corporation Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
EP3112468A1 (en) * 1998-05-15 2017-01-04 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
EP1865061A3 (en) * 1998-05-15 2007-12-19 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
EP1897948A1 (en) * 1998-09-17 2008-03-12 ZymoGenetics, Inc. Mammalian transforming growth factor beta 9
IL143600A0 (en) * 1999-01-11 2002-04-21 Schering Corp Interleukin-17 related mammalian cytokines, polynucleotides encoding them and their uses
WO2000061754A2 (en) * 1999-04-09 2000-10-19 Curagen Corporation Human proteins and polynucleotides encoding them
ES2458349T3 (es) * 1999-12-23 2014-05-05 Genentech, Inc. Polipéptidos homólogos IL-17 y usos terapéuticos de los mismos
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
JP2016047051A (ja) * 1999-12-23 2016-04-07 ジェネンテック， インコーポレイテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途
EP1259253A2 (en) * 2000-02-29 2002-11-27 ZymoGenetics, Inc. Methods for promoting production of myelin by schwann cells
US6569419B2 (en) 2000-02-29 2003-05-27 Zymogenetics, Inc. Methods for promoting production of myelin by Schwann cells
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2452233A1 (en) * 2001-03-26 2002-10-03 Zymogenetics, Inc. Method of inducing proliferation of retinal stem cells
CN101531715A (zh) * 2001-04-20 2009-09-16 津莫吉尼蒂克斯公司 细胞因子蛋白质家族
JP2009505967A (ja) * 2005-08-04 2009-02-12 ザイモジェネティクス， インコーポレイテッド Ｉｌ−１７ｂを用いた創傷の処置方法
CA2669109A1 (en) * 2006-11-08 2008-06-19 Zymogenetics, Inc. Il-17b for use in wound healing
US20090317400A1 (en) 2008-05-05 2009-12-24 Krzysztof Masternak Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof
MX2011011729A (es) 2009-05-05 2012-04-10 Novimmune Sa Anticuerpo anti il-17f y metodos de uso de los mismos.

Also Published As

Publication number Publication date
EP0977861A1 (en) 2000-02-09
NO995182L (no) 1999-12-22
DE69824719T2 (de) 2005-06-30
IL132496A0 (en) 2001-03-19
EA199900869A1 (ru) 2000-12-25
AU7152798A (en) 1998-11-24
JP4216343B2 (ja) 2009-01-28
DE69824719D1 (de) 2004-07-29
WO1998049310A1 (en) 1998-11-05
NO995182D0 (no) 1999-10-22
CN1258315A (zh) 2000-06-28
NZ500885A (en) 2001-06-29
EP0977861B1 (en) 2004-06-23
ATE269901T1 (de) 2004-07-15
ES2223127T3 (es) 2005-02-16
PL336470A1 (en) 2000-06-19
AU736362B2 (en) 2001-07-26
JP2002509432A (ja) 2002-03-26
CA2288360A1 (en) 1998-11-05
KR20010012111A (ko) 2001-02-15

Similar Documents

Publication Publication Date Title
BR9809778A (pt) Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DE69841102D1 (de) Monoklonaler antikörper gegen ein prion protein und dessen verwendung zum nachweis von prionen
IL193886A0 (en) Antibodies that bind to ldcam sequences
WO1998050433A3 (en) Human monoclonal antibodies to epidermal growth factor receptor
ATE394484T1 (de) Smad 6 und dessen anwendungen
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
IT1271461B (it) Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso.
BR9500271B1 (pt) seqüência de dna recombinante, vetor, células procarióticas e de fungo transformadas e proteìna com atividade sacarose-isomerase e com atividade de platinase e/ou trehalulase.
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
PT759942E (pt) Receptor de interleucina-15
BR9806318A (pt) Polipeptìdeo pde8, polinucleotìdeo codificando o mesmo, dna, polinucleotìdeo anti-sentido, construção de expressão, célula hospedeira, processo para produzir um polipeptìdeo pde8, anticorpo, hibridoma, anticorpo anti-idiotipo, processo para identificar um composto parceiro de ligação espefcìfico de um polipeptìdeo pde8a, e de polinucleotìdeo pde8a, composto, e, composição.
DE69333382D1 (de) Hyaluronan rezeptor (rezeptor durch hyaluronan verurzachte bewelichkeit) und hyaluronan bindende peptide
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
HK1037209A1 (en) Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO1999029720A3 (en) Mammalian alpha helical protein-1
AU5990100A (en) ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
DK599189A (da) Apo-ai-polypeptid og dets anvendelse, monoklonalt antistof, som reagerer dermed, samt hybridoma til dettes fremstilling
WO2001046419A3 (en) Mammalian prion proteins; related reagents and methods
WO1999000411A3 (en) Two new wd-40 proteins

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.